TrialInvestigational new drugs2016

Intravenous and intraperitoneal paclitaxel with S-1 for treatment of refractory pancreatic cancer with malignant ascites.

Naminatsu Takahara et al.PubMed ↗Publisher ↗

No numbers read from the abstract.